Zhenghang Wang, Wenhua Li, Sai Ge, Xuan Jin, Ting Xu, Jian Li, Lin Shen. "A phase Ib, open-label, clinical trial of JAB21822 combined with second-line chemotherapy for metastatic colorectal cancer with KRAS G12C mutation.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.3544